11055 FLINTKOTE AVENUE, SAN DIEGO, CA
Oncology and Amend their 2017 Exclusive License Agreement
Reports Second Quarter 2026 Results and Provides Business Update
Announces $10 Million Registered Direct Offering
Annual Meeting Results: Six Directors Elected at Cardiff Oncology, Inc.
Investor Presentation
Cardiff Oncology, Inc. Sues NMS Over License Agreement Dispute
Other Events
Reports First Quarter 2026 Results and Provides Business Update
Q2
Q1
FY 2024
Q3
FY 2023
Registration Statement for Securities to be Offered to Employees
Prospectus filed pursuant to Rule 424(b)(5)
Effectiveness Notice
Amended Registration Statement for Securities Offered under a Shelf Registration
Registration Statement for Securities Offered under a Shelf Registration
Definitive Proxy Statement
Additional Proxy Materials
Amended Schedule 13G - Ownership Report
Statement of Changes in Beneficial Ownership
Correspondence
Submission Upload